Kate Lee Elected Vice President of ISCB
We are delighted to announce that Katherine Lee has been elected as the Vice President of the International Society for Clinical Biostatistics (ISCB).
Kate brings a wealth of experience and expertise to this prestigious role. In addition to her leadership role in ViCBiostat, she is the co-lead of the Clinical Epidemiology & Biostatistics (CEBU) unit at MCRI, a lead investigator for the Australian Trials Methodology (AusTriM) Research Network and co-chair and founding member of the Australian Clinical Trials Alliance Statistics in Trials Interest Group (ACTA-STInG). Her research in multiple imputation methods for missing data and adaptive platform trials is internationally recognised, making significant contributions to the field and influencing best practices in clinical biostatistics worldwide.
As Vice President of ISCB, Kate will play a crucial role in advancing the society's mission to promote high standards of biostatistical practice and research. Her leadership is expected to foster international collaboration and drive innovative methodologies in clinical biostatistics.
Congratulations to Kate on this remarkable achievement! We look forward to seeing the positive impact of her leadership on the global biostatistics community.
